BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1602514)

  • 21. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F; Raina N; Richardson R
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V
    Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract]   [Full Text] [Related]  

  • 23. Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites.
    Angeli P; Sanyal A; Moller S; Alessandria C; Gadano A; Kim R; Sarin SK; Bernardi M;
    Liver Int; 2013 Jan; 33(1):16-23. PubMed ID: 22507181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatorenal syndrome: definition, pathophysiology, clinical features and management.
    Bataller R; Sort P; Ginès P; Arroyo V
    Kidney Int Suppl; 1998 May; 66():S47-53. PubMed ID: 9573573
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
    Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
    Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.
    Møller S; Krag A; Bendtsen F
    Liver Int; 2014 Sep; 34(8):1153-63. PubMed ID: 24673771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatorenal syndrome: incidence, predictive factors and prognosis].
    Moreau R
    Gastroenterol Clin Biol; 1994; 18(5):541-3. PubMed ID: 7813880
    [No Abstract]   [Full Text] [Related]  

  • 30. Ascites.
    Gordon FD
    Clin Liver Dis; 2012 May; 16(2):285-99. PubMed ID: 22541699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of renal dysfunction in cirrhosis.
    Ginès P; Sort P
    Digestion; 1998 Jul; 59 Suppl 2():11-5. PubMed ID: 9718412
    [No Abstract]   [Full Text] [Related]  

  • 32. Resorption of ascites in decompensated cirrhosis.
    Henriksen JH; Ring-Larsen H; Winkler K
    J Lab Clin Med; 1985 Jun; 105(6):759-60. PubMed ID: 3998624
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatorenal syndrome. Cases report].
    Niemczyk S; Romejko-Ciepielewska K; Gomółka M; Skorupińska A; Kulicki P; Pyrza M; Matuszkiewicz-Rowińska J
    Pol Arch Med Wewn; 2005 Oct; 114(4):982-8. PubMed ID: 16789525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.
    Krag A; Møller S; Henriksen JH; Holstein-Rathlou NH; Larsen FS; Bendtsen F
    Hepatology; 2007 Dec; 46(6):1863-71. PubMed ID: 18027874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical characteristics and prognostic criteria in alcoholic hepatitis and alcoholic hepatitis with cirrhosis].
    García Rodríguez JF; Tomé Martínez de Rituerto S; Martínez Vázquez F; Gude Sanpedro F; Rodríguez López I; Barrio Gómez E
    Rev Esp Enferm Apar Dig; 1989 Sep; 76(3):210-4. PubMed ID: 2813910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment of liver failure and hepatorenal syndrome with orthotopic liver transplantation.
    Detroz B; Honore P; Monami B; Meurisse M; Canivet JL; Legrand M; Damas P; Jacquet N
    Acta Gastroenterol Belg; 1992; 55(4):350-7. PubMed ID: 1462747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of the hepatorenal syndrome and potential for therapy.
    Levy M
    Am J Cardiol; 1987 Dec; 60(17):66I-72I. PubMed ID: 3687808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of ascites on splanchnic and systemic hemodynamics in patients with alcoholic cirrhosis].
    Cereda JM; Braillon A; Ozier Y; Moreau R; Gaudin C; Lebrec D
    Gastroenterol Clin Biol; 1989 May; 13(5):495-8. PubMed ID: 2753286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal damage in liver cirrhosis: pathophysiology and management].
    Yamamoto T; Hishida A
    Nihon Rinsho; 1994 Jan; 52(1):159-64. PubMed ID: 8114286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insight into volume overload and hepatorenal syndrome in cirrhosis, "the hepatorenal reflex hypothesis".
    Rzouq F; Alahdab F; Olyaee M
    Am J Med Sci; 2014 Sep; 348(3):244-8. PubMed ID: 24805785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.